Literature DB >> 8421170

Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats.

M Kauppi1, L Saarinen, H Käyhty.   

Abstract

Haemophilus influenzae type b (Hib) conjugate vaccines reduced oropharyngeal carriage of Hib among children in Finland and the United States. To study the mechanisms of this reduction, a colonization model in infant rats with passively administered antibodies was developed. Of the pups, 94% were colonized 48 h and 64% 7 days after intranasal inoculation with approximately 2500 cfu of Hib. Intranasally administered anti-Hib antibodies, including human IgG and both serum and secretory IgA (sIgA) as well as murine monoclonal anti-Hib capsular polysaccharide (PS) of IgG1 isotype, given simultaneously with, before, or after bacteria, significantly reduced nasopharyngeal colonization by Hib. Hib colonization was also significantly reduced when the antibodies were given intraperitoneally, with a resultant anti-Hib PS serum concentration of > or = 7 micrograms/mL. Thus, anti-Hib PS antibodies, both sIgA and IgG, can function on the mucosal surface and prevent colonization.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421170     DOI: 10.1093/infdis/167.2.365

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Effects of sample collection and storage methods on antipneumococcal immunoglobulin A in saliva.

Authors:  A Nurkka; J Obiero; H Käyhty; J A G Scott
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

Review 2.  Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.

Authors:  Q Zhang; A Finn
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

3.  Haemophilus influenzae: then and now.

Authors:  J Z Jordens; M P Slack
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

4.  Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines.

Authors:  M Kauppi-Korkeila; L Saarinen; J Eskola; H Käyhty
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

5.  Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.

Authors:  Q Zhang; R Lakshman; R Burkinshaw; S Choo; J Everard; S Akhtar; A Finn
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Development and characterization of a Staphylococcus aureus nasal colonization model in mice.

Authors:  K B Kiser; J M Cantey-Kiser; J C Lee
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice.

Authors:  Qi Cheng; Steven Debol; Hong Lam; Ron Eby; Lorri Edwards; Yury Matsuka; Stephen B Olmsted; P Patrick Cleary
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

8.  Antibodies to Haemophilus influenzae type b polysaccharide affect bacterial adherence and multiplication.

Authors:  L van Alphen; P Eijk; H Käyhty; J van Marle; J Dankert
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Study of capsular polysaccharide from Vibrio parahaemolyticus.

Authors:  Yu-Chi Hsieh; Shu-Mei Liang; Wan-Ling Tsai; Yee-Hsiung Chen; Teh-Yung Liu; Chi-Ming Liang
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Enhancement of serum and mucosal immune responses to a Haemophilus influenzae Type B vaccine by intranasal delivery.

Authors:  Stefan Fernandez; Emily D Cisney; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2013-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.